In our cohort, ACP3 mRNA levels were strongly downregulated in all of the high-grade patients and in the vast majority of low- and intermediate-grade patients, suggesting that ACP3 downregulation represents an early event during PCa evolution. This evidence concerns the gene ACP3 and posterior cortical atrophy.